 | • レポートコード：QYR2104Z5754 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、結核治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（活動性結核、潜在性結核）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・結核治療の市場動向 ・企業の競争状況、市場シェア ・結核治療の種類別市場規模（活動性結核、潜在性結核） ・結核治療の用途別市場規模（病院、クリニック） ・結核治療の北米市場規模2016-2027（アメリカ、カナダ） ・結核治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・結核治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結核治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・結核治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Bayer、Eli Lilly、Labatec Pharma、Macleods Pharmaceuticals、Mylan、Novatis、Otsuka、Patheon、Pfizer） ・結論 |
Market Analysis and Insights: Global Tuberculosis Treatment Market
The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis Treatment market.
Global Tuberculosis Treatment Scope and Market Size
Tuberculosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Active TB
Latent TB
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Bayer
Eli Lilly
Labatec Pharma
Macleods Pharmaceuticals
Mylan
Novatis
Otsuka
Patheon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Active TB
1.2.3 Latent TB
1.3 Market by Application
1.3.1 Global Tuberculosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Treatment Market Perspective (2016-2027)
2.2 Tuberculosis Treatment Growth Trends by Regions
2.2.1 Tuberculosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis Treatment Industry Dynamic
2.3.1 Tuberculosis Treatment Market Trends
2.3.2 Tuberculosis Treatment Market Drivers
2.3.3 Tuberculosis Treatment Market Challenges
2.3.4 Tuberculosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Treatment Revenue
3.4 Global Tuberculosis Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Treatment Revenue in 2020
3.5 Tuberculosis Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Treatment Breakdown Data by Type
4.1 Global Tuberculosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis Treatment Forecasted Market Size by Type (2022-2027)
5 Tuberculosis Treatment Breakdown Data by Application
5.1 Global Tuberculosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tuberculosis Treatment Market Size (2016-2027)
6.2 North America Tuberculosis Treatment Market Size by Type
6.2.1 North America Tuberculosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis Treatment Market Size by Type (2016-2027)
6.3 North America Tuberculosis Treatment Market Size by Application
6.3.1 North America Tuberculosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis Treatment Market Size by Application (2016-2027)
6.4 North America Tuberculosis Treatment Market Size by Country
6.4.1 North America Tuberculosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Tuberculosis Treatment Market Size (2016-2027)
7.2 Europe Tuberculosis Treatment Market Size by Type
7.2.1 Europe Tuberculosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis Treatment Market Size by Type (2016-2027)
7.3 Europe Tuberculosis Treatment Market Size by Application
7.3.1 Europe Tuberculosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis Treatment Market Size by Application (2016-2027)
7.4 Europe Tuberculosis Treatment Market Size by Country
7.4.1 Europe Tuberculosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tuberculosis Treatment Market Size (2016-2027)
9.2 Latin America Tuberculosis Treatment Market Size by Type
9.2.1 Latin America Tuberculosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis Treatment Market Size by Application
9.3.1 Latin America Tuberculosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis Treatment Market Size by Country
9.4.1 Latin America Tuberculosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Tuberculosis Treatment Introduction
11.1.4 Sanofi Revenue in Tuberculosis Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Tuberculosis Treatment Introduction
11.2.4 Bayer Revenue in Tuberculosis Treatment Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Tuberculosis Treatment Introduction
11.3.4 Eli Lilly Revenue in Tuberculosis Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Labatec Pharma
11.4.1 Labatec Pharma Company Details
11.4.2 Labatec Pharma Business Overview
11.4.3 Labatec Pharma Tuberculosis Treatment Introduction
11.4.4 Labatec Pharma Revenue in Tuberculosis Treatment Business (2016-2021)
11.4.5 Labatec Pharma Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Details
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Tuberculosis Treatment Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2016-2021)
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Tuberculosis Treatment Introduction
11.6.4 Mylan Revenue in Tuberculosis Treatment Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Novatis
11.7.1 Novatis Company Details
11.7.2 Novatis Business Overview
11.7.3 Novatis Tuberculosis Treatment Introduction
11.7.4 Novatis Revenue in Tuberculosis Treatment Business (2016-2021)
11.7.5 Novatis Recent Development
11.8 Otsuka
11.8.1 Otsuka Company Details
11.8.2 Otsuka Business Overview
11.8.3 Otsuka Tuberculosis Treatment Introduction
11.8.4 Otsuka Revenue in Tuberculosis Treatment Business (2016-2021)
11.8.5 Otsuka Recent Development
11.9 Patheon
11.9.1 Patheon Company Details
11.9.2 Patheon Business Overview
11.9.3 Patheon Tuberculosis Treatment Introduction
11.9.4 Patheon Revenue in Tuberculosis Treatment Business (2016-2021)
11.9.5 Patheon Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Tuberculosis Treatment Introduction
11.10.4 Pfizer Revenue in Tuberculosis Treatment Business (2016-2021)
11.10.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Tuberculosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Active TB
Table 3. Key Players of Latent TB
Table 4. Global Tuberculosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Tuberculosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tuberculosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Tuberculosis Treatment Market Share by Regions (2016-2021)
Table 8. Global Tuberculosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Tuberculosis Treatment Market Share by Regions (2022-2027)
Table 10. Tuberculosis Treatment Market Trends
Table 11. Tuberculosis Treatment Market Drivers
Table 12. Tuberculosis Treatment Market Challenges
Table 13. Tuberculosis Treatment Market Restraints
Table 14. Global Tuberculosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Tuberculosis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Tuberculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Treatment as of 2020)
Table 17. Ranking of Global Top Tuberculosis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Tuberculosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tuberculosis Treatment Product Solution and Service
Table 21. Date of Enter into Tuberculosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tuberculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Tuberculosis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Tuberculosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Tuberculosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Tuberculosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Tuberculosis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Tuberculosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Tuberculosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Tuberculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Tuberculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Tuberculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Tuberculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Tuberculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Tuberculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Tuberculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Tuberculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Tuberculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Tuberculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Tuberculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Tuberculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Tuberculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Tuberculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tuberculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tuberculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tuberculosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Tuberculosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Tuberculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Tuberculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Tuberculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Tuberculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Tuberculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Tuberculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Tuberculosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Tuberculosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tuberculosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tuberculosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tuberculosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Tuberculosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Tuberculosis Treatment Product
Table 64. Sanofi Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Tuberculosis Treatment Product
Table 69. Bayer Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Tuberculosis Treatment Product
Table 74. Eli Lilly Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Labatec Pharma Company Details
Table 77. Labatec Pharma Business Overview
Table 78. Labatec Pharma Tuberculosis Treatment Product
Table 79. Labatec Pharma Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 80. Labatec Pharma Recent Development
Table 81. Macleods Pharmaceuticals Company Details
Table 82. Macleods Pharmaceuticals Business Overview
Table 83. Macleods Pharmaceuticals Tuberculosis Treatment Product
Table 84. Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Macleods Pharmaceuticals Recent Development
Table 86. Mylan Company Details
Table 87. Mylan Business Overview
Table 88. Mylan Tuberculosis Treatment Product
Table 89. Mylan Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 90. Mylan Recent Development
Table 91. Novatis Company Details
Table 92. Novatis Business Overview
Table 93. Novatis Tuberculosis Treatment Product
Table 94. Novatis Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 95. Novatis Recent Development
Table 96. Otsuka Company Details
Table 97. Otsuka Business Overview
Table 98. Otsuka Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 99. Otsuka Recent Development
Table 100. Patheon Company Details
Table 101. Patheon Business Overview
Table 102. Patheon Tuberculosis Treatment Product
Table 103. Patheon Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 104. Patheon Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Tuberculosis Treatment Product
Table 108. Pfizer Revenue in Tuberculosis Treatment Business (2016-2021) & (US$ Million)
Table 109. Pfizer Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Active TB Features
Figure 3. Latent TB Features
Figure 4. Global Tuberculosis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Tuberculosis Treatment Report Years Considered
Figure 8. Global Tuberculosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Tuberculosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tuberculosis Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Tuberculosis Treatment Market Share by Regions (2022-2027)
Figure 12. Global Tuberculosis Treatment Market Share by Players in 2020
Figure 13. Global Top Tuberculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Tuberculosis Treatment Revenue in 2020
Figure 15. Global Tuberculosis Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Tuberculosis Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Tuberculosis Treatment Market Share by Type (2016-2027)
Figure 19. North America Tuberculosis Treatment Market Share by Application (2016-2027)
Figure 20. North America Tuberculosis Treatment Market Share by Country (2016-2027)
Figure 21. United States Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Tuberculosis Treatment Market Share by Type (2016-2027)
Figure 25. Europe Tuberculosis Treatment Market Share by Application (2016-2027)
Figure 26. Europe Tuberculosis Treatment Market Share by Country (2016-2027)
Figure 27. Germany Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Tuberculosis Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Tuberculosis Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Tuberculosis Treatment Market Share by Region (2016-2027)
Figure 37. China Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Tuberculosis Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Tuberculosis Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Tuberculosis Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Tuberculosis Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Tuberculosis Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Tuberculosis Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Tuberculosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 57. Bayer Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 58. Eli Lilly Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 59. Labatec Pharma Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 60. Macleods Pharmaceuticals Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 61. Mylan Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 62. Novatis Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 63. Otsuka Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 64. Patheon Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Tuberculosis Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の結核治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…- 世界の結核診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnosis and Treatment Market The global Tuberculosis Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の結核診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnosis and Treatment Market The global Tuberculosis Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の潜在性結核感染症（LTBI）検査市場規模・現状・予測（2021年-2027年） The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc. Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc. Diagnosing and treating latent tuberculosis (T…
- 世界の結核診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnostic Market The global Tuberculosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…